174 related articles for article (PubMed ID: 24797522)
1. Kidney stones and cardiovascular risk: a meta-analysis of cohort studies.
Liu Y; Li S; Zeng Z; Wang J; Xie L; Li T; He Y; Qin X; Zhao J
Am J Kidney Dis; 2014 Sep; 64(3):402-10. PubMed ID: 24797522
[TBL] [Abstract][Full Text] [Related]
2. History of kidney stones and the risk of coronary heart disease.
Ferraro PM; Taylor EN; Eisner BH; Gambaro G; Rimm EB; Mukamal KJ; Curhan GC
JAMA; 2013 Jul; 310(4):408-15. PubMed ID: 23917291
[TBL] [Abstract][Full Text] [Related]
3. Homocysteine as a risk factor for cardiovascular disease in patients treated by dialysis: a meta-analysis.
Heinz J; Kropf S; Luley C; Dierkes J
Am J Kidney Dis; 2009 Sep; 54(3):478-89. PubMed ID: 19359080
[TBL] [Abstract][Full Text] [Related]
4. Body mass index, coronary heart disease and stroke in Swedish women. A prospective 19-year follow-up in the BEDA study.
Rosengren A; Wilhelmsen L; Lappas G; Johansson S
Eur J Cardiovasc Prev Rehabil; 2003 Dec; 10(6):443-50. PubMed ID: 14671467
[TBL] [Abstract][Full Text] [Related]
5. Schizophrenia and the risk of cardiovascular diseases: a meta-analysis of thirteen cohort studies.
Fan Z; Wu Y; Shen J; Ji T; Zhan R
J Psychiatr Res; 2013 Nov; 47(11):1549-56. PubMed ID: 23953755
[TBL] [Abstract][Full Text] [Related]
6. Nephrolithiasis Among Middle Aged and Elderly Urban Chinese: A Report from Prospective Cohort Studies in Shanghai.
Shu X; Cai H; Xiang YB; Li H; Lipworth L; Miller NL; Zheng W; Shu XO; Hsi RS
J Endourol; 2017 Dec; 31(12):1327-1334. PubMed ID: 29048227
[TBL] [Abstract][Full Text] [Related]
7. [Incidence risk of major cardiovascular events among socio-occupational classes. 11-year follow-up of the MONICA Brianza and PAMELA cohorts].
Ferrario M; Veronesi G; Corrao G; Fomari C; Sega R; Borchini R; Battaini E; Corda R; Cesana G
G Ital Med Lav Ergon; 2005; 27(3):275-8. PubMed ID: 16240572
[TBL] [Abstract][Full Text] [Related]
8. Kidney stones may increase the risk of coronary heart disease and stroke: A PRISMA-Compliant meta-analysis.
Peng JP; Zheng H
Medicine (Baltimore); 2017 Aug; 96(34):e7898. PubMed ID: 28834909
[TBL] [Abstract][Full Text] [Related]
9. Quantitative retinal venular caliber and risk of cardiovascular disease in older persons: the cardiovascular health study.
Wong TY; Kamineni A; Klein R; Sharrett AR; Klein BE; Siscovick DS; Cushman M; Duncan BB
Arch Intern Med; 2006 Nov; 166(21):2388-94. PubMed ID: 17130394
[TBL] [Abstract][Full Text] [Related]
10. Joint effects of systolic blood pressure and serum cholesterol on cardiovascular disease in the Asia Pacific region.
Asia Pacific Cohort Studies Collaboration
Circulation; 2005 Nov; 112(22):3384-90. PubMed ID: 16301345
[TBL] [Abstract][Full Text] [Related]
11. Association of kidney stones with atherosclerotic cardiovascular disease among adults in the United States: Considerations by race-ethnicity.
Glover LM; Bass MA; Carithers T; Loprinzi PD
Physiol Behav; 2016 Apr; 157():63-6. PubMed ID: 26812589
[TBL] [Abstract][Full Text] [Related]
12. Cognitive impairment and risk of cardiovascular events and mortality.
O'Donnell M; Teo K; Gao P; Anderson C; Sleight P; Dans A; Marzona I; Bosch J; Probstfield J; Yusuf S
Eur Heart J; 2012 Jul; 33(14):1777-86. PubMed ID: 22551598
[TBL] [Abstract][Full Text] [Related]
13. Advanced chronic kidney disease, cardiovascular events and the effect of diabetes: data from the Atherosclerosis and Folic Acid Supplementation Trial.
Zoungas S; Lui M; Kerr PG; Teede HJ; McNeil JJ; McGrath BP; Polkinghorne KR
Intern Med J; 2011 Dec; 41(12):825-32. PubMed ID: 20298505
[TBL] [Abstract][Full Text] [Related]
14. Nationwide cohort study of the leukotriene receptor antagonist montelukast and incident or recurrent cardiovascular disease.
Ingelsson E; Yin L; Bäck M
J Allergy Clin Immunol; 2012 Mar; 129(3):702-707.e2. PubMed ID: 22244598
[TBL] [Abstract][Full Text] [Related]
15. Kidney stones and cardiovascular events: a cohort study.
Alexander RT; Hemmelgarn BR; Wiebe N; Bello A; Samuel S; Klarenbach SW; Curhan GC; Tonelli M;
Clin J Am Soc Nephrol; 2014 Mar; 9(3):506-12. PubMed ID: 24311706
[TBL] [Abstract][Full Text] [Related]
16. Albuminuria, estimated GFR, traditional risk factors, and incident cardiovascular disease: the PREVEND (Prevention of Renal and Vascular Endstage Disease) study.
Smink PA; Lambers Heerspink HJ; Gansevoort RT; de Jong PE; Hillege HL; Bakker SJ; de Zeeuw D
Am J Kidney Dis; 2012 Nov; 60(5):804-11. PubMed ID: 22835901
[TBL] [Abstract][Full Text] [Related]
17. The Risk of Coronary Heart Disease in Patients with Kidney Stones: A Systematic Review and Meta-analysis.
Cheungpasitporn W; Thongprayoon C; Mao MA; O'Corragain OA; Edmonds PJ; Erickson SB
N Am J Med Sci; 2014 Nov; 6(11):580-5. PubMed ID: 25535607
[TBL] [Abstract][Full Text] [Related]
18. Meta-analysis of rare events: an update and sensitivity analysis of cardiovascular events in randomized trials of rosiglitazone.
Dahabreh IJ; Economopoulos K
Clin Trials; 2008; 5(2):116-20. PubMed ID: 18375649
[TBL] [Abstract][Full Text] [Related]
19. Urinary Stones and Risk of Coronary Heart Disease and Stroke: the Japan Public Health Center-Based Prospective Study.
Arafa A; Eshak ES; Iso H; Shirai K; Muraki I; Sawada N; Tsugane S;
J Atheroscler Thromb; 2020 Nov; 27(11):1208-1215. PubMed ID: 32507830
[TBL] [Abstract][Full Text] [Related]
20. Serum total adiponectin level and the risk of cardiovascular disease in general population: a meta-analysis of 17 prospective studies.
Hao G; Li W; Guo R; Yang JG; Wang Y; Tian Y; Liu MY; Peng YG; Wang ZW
Atherosclerosis; 2013 May; 228(1):29-35. PubMed ID: 23489345
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
